Chronic Stable Angina
38
1
3
20
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.3%
2 terminated out of 38 trials
90.9%
+4.4% vs benchmark
18%
7 trials in Phase 3/4
20%
4 of 20 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 20 completed trials
Clinical Trials (38)
Wave Crossover ECP Study for Simplified Therapy
REDUCER-I: An Observational Study of the Neovasc Reducer™ System
LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients
Enhancing Cardiac Rehabilitation Through Behavioral Nudges
Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions
Yinxingmihuan Oral Solution in Treatment of Chest Pain After PCI
Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries
PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy
The Effect of Danzhu Fuyuan Granule as Adjunctive Therapy for Chronic Stable Angina, Vascular Dementia and Idiopathic Membranous Nephropathy: A Bayesian Basket Trial
Coronary Arteriogenetic Heparinized Exercise
Mindfulness & Stress Management Study for Cardiac Patients
A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions
Multi-slice CT Coronary Angiography in Patients With Stable Angina
MYocardial DAmage AND MIcrobiota STUDY
Myocardial Damage and Music Study
Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy
Text Message Intervention to Improve Cardiac Rehab Participation
Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)
Bioequivalency Study of Amlodipine Tablets Under Fasting Conditions
Bioequivalency Study of Amlodipine Tablets Under Fed Conditions